A randomized Phase II study of tegafur/uracil (UFT), oral Leucovorin and irinotecan, combination therapy (TEGAFIRI) plus bevacizumab versus FOLFIRI plus bevacizumab for the first-line treatment of patients with metastatic colorectal cancer

被引：0
|
作者：
Hasegawa, H. [1 ]
Endo, T. [1 ]
Ochiai, D. [1 ]
Uchida, H. [2 ]
Okabayashi, T. [1 ]
Imai, S. [3 ]
Ishii, Y.
Tsuruta, M.
Kitagawa, Y.
机构：
[1] Keio Univ, Tokyo, Japan
[2] Saitama Social Insurance Hosp, Saitama, Japan
[3] Hiratsuka City Hosp, Hiratsuka, Kanagawa, Japan
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2390
引用
收藏
页码：S557 / S557
页数：1
相关论文
共 50 条
  • [1] Phase II Study of Oral Tegafur/Uracil and Leucovorin plus Bevacizumab as a First-Line Therapy for Elderly Patients with Advanced or Metastatic Colorectal Cancer
    Mizushima, Tsunekazu
    Tamagawa, Hiroshi
    Matsuda, Chu
    Murata, Kohei
    Fukunaga, Mutsumi
    Ota, Hirofumi
    Hasegawa, Junichi
    Tsujie, Masaki
    Fukuzaki, Takayuki
    Hata, Taishi
    Takemasa, Ichiro
    Ikeda, Masataka
    Yamamoto, Hirofumi
    Sekimoto, Mitsugu
    Nezu, Riichiro
    Doki, Yuichiro
    Mori, Masaki
    ONCOLOGY, 2015, 89 (03) : 152 - 158
  • [2] Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI): first-line therapy for metastatic colorectal cancer
    J-P Delord
    J Bennouna
    P Artru
    H Perrier
    F Husseini
    F Desseigne
    E François
    R Faroux
    D Smith
    P Piedbois
    H Naman
    J Y Douillard
    R Bugat
    British Journal of Cancer, 2007, 97 : 297 - 301
  • [3] Phase II study of UFT with leucovorin and irinotecan (TEGAFIRI):: first-line therapy for metastatic colorectal cancer
    Delord, J-P
    Bennouna, J.
    Artru, P.
    Perrier, H.
    Husseini, F.
    Desseigne, F.
    Francois, E.
    Faroux, R.
    Smith, D.
    Piedbois, P.
    Naman, H.
    Douillard, J. Y.
    Bugat, R.
    BRITISH JOURNAL OF CANCER, 2007, 97 (03) : 297 - 301
  • [4] Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer
    Kopetz, S.
    Glover, K. Y.
    Eng, C.
    Wolff, R. A.
    Chang, D. Z.
    Adinin, R. B.
    Morris, J.
    Abbruzzese, J. L.
    Hoff, P. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [5] Irinotecan/capecitabine (XELIRI) plus bevacizumab versus irinotecan/fluorouracil/leucovorin (FOLFIRI) plus bevacizumab as first-line treatment in patients with metastatic colorectal cancer: A randomized phase III trial of the Hellenic Cooperative Oncology Group (HeCOG).
    Pectasides, D. G.
    Xanthakis, I.
    Makatsoris, T.
    Samantas, E.
    Varthalitis, I.
    Papaxoinis, G.
    Papakotoulas, P.
    Boumakis, E.
    Papandreou, C.
    Fountzilas, G.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [6] Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer: Final results
    Kopetz, S.
    Glover, K.
    Eng, C.
    Wolff, R.
    Chang, D.
    Adinin, R.
    Morris, J.
    Abbruzzese, S.
    Hoff, P.
    ANNALS OF ONCOLOGY, 2007, 18 : VII80 - VII80
  • [7] Phase II Study of Tegafur/Uracil and Leucovorin plus Bevacizumab for Elderly Patients with Advanced Colorectal Cancer
    Murata, Kohei
    Mizushima, Tsunekazu
    Tamagawa, Koji
    Matsuda, Chu
    Fukunaga, Mutsumi
    Hata, Taishi
    Nezu, Riichiro
    Yamamoto, Hirofumi
    Doki, Yuichiro
    Mori, Masaki
    ANNALS OF ONCOLOGY, 2016, 27
  • [8] Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer
    Sobrero, Alberto
    Ackland, Stephen
    Clarke, Stephen
    Perez-Carrion, Ramon
    Chiara, Silvia
    Gapski, John
    Mainwaring, Paul
    Langer, Bernd
    Young, Scott
    ONCOLOGY, 2009, 77 (02) : 113 - 119
  • [9] A COMPARISON OF XELIRI PLUS BEVACIZUMAB WITH FOLFIRI PLUS BEVACIZUMAB AS FIRST-LINE SETTING IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Ahmet, Bilici
    Uygun, Kazim
    Kaya, Serap
    Ustaalioglu, Bala Basak Oven
    Yildiz, Ramazan
    Temiz, Suleyman
    Seker, Mesut
    Aksu, Gorkem
    Cabuk, Devrim
    Gumus, Mahmut
    ANNALS OF ONCOLOGY, 2012, 23 : 98 - 99
  • [10] 'A phase II study of oral uracil/ftorafur (UFT®) plus leucovorin combined with oxaliplatin (TEGAFOX) as first-line treatment in patients with metastatic colorectal cancer'
    Bennouna, J
    Perrier, H
    Paillot, B
    Priou, F
    Jacob, JH
    Hebbar, M
    Bordenave, S
    Seitz, JF
    Cvitkovic, F
    Dorval, E
    Malek, K
    Tonelli, D
    Douillard, JY
    BRITISH JOURNAL OF CANCER, 2006, 94 (01) : 69 - 73
12345